Bumetanide for autism : more eye contact, less amygdala activation

Hadjikhani N, Johnels JA, Lassalle A, Zürcher NR, Hippolyte L, Gillberg C,
Lemonnier E, Ben-Ari Y.
Scientific Reports. 2018 February 26
Télécharger l’article

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.

Lemonnier E, Villeneuve N, Sonie S, Serret S, Rosier A, Roue M, Brosset P, Viellard M, Bernoux D, Rondeau S, Thummler S, Ravel D, Ben-Ari Y.
Transl Psychiatry. 2017 March 14 14;10:90.
Télécharger l’article

Correspondence: Progress in autism research and postgenomic studies

Ben-Ari Y.
The Lancet Neurology. Vol 15, February 2016
Télécharger l’article

Is birth a critical period in the pathogenesis of autism spectrum disorders?

Ben-Ari Y.
Nature Reviews Neuroscience. 2015 Jul 8.
Télécharger l’article

Improving emotional face perception in autism with diuretic bumetanide: a proof-of-concept behavioral and functional brain imaging pilot study.

Hadjikhani N, Zürcher NR, Rogier O, Ruest T, Hippolyte L, Ben-Ari Y, Lemonnier E.
Autism. 2015 Feb ; 19(2):149-57.
Télécharger l’article

Synapses as therapeutic targets for autism spectrum disorders: an international symposium held in pavia on july 4th, 2014.

Curatolo P, Ben-Ari Y, Bozzi Y, Catania MV, D’Angelo E, Mapelli L, Oberman LM, Rosenmund C, Cherubini E.
Front Cell Neurosci. 2014 Sep 29 ; 8:309.

Response to Comment on “Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring”.

Eftekhari S, Shahrokhi A, Tsintsadze V, Nardou R, Brouchoud C, Conesa M, Burnashev N, Ferrari DC, Ben-Ari Y.
Science. 2014 Oct 10 ; 346 (6206): 176.
Télécharger l’article

Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring.

Tyzio R, Nardou R, Ferrari DC, Tsintsadze T, Shahrokhi A, Eftekhari S, Khalilov I, Tsintsadze V, Brouchoud C, Chazal G, Lemonnier E, Lozovaya N, Burnashev N, Ben-Ari Y.
Science. 2014 Feb 7 ; 343 (6171): 675-679.
Télécharger l’article

A randomised controled trial of bumetanide in the treatment of autism in children.

Lemonnier E, Degrez C, Phelep M, Tyzio R, Josse F, Grandgeorge M, Hadjikhani N, Ben-Ari Y.
Transl Psychiatry. 2012 Dec 11 ; 2:e202.
Télécharger l’article .pdf

The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects.

Lemonnier E, Ben-Ari Y.
Acta Paediatr. 2010 Dec ; 99(12):1885-8.
Télécharger l’article